2-[[(3R)-4-(4-Tert-butylphenyl)-3-[[2-(4-methoxyphenyl)sulfanyl-5-[methyl(propan-2-yl)sulfamoyl]benzoyl]amino]butanoyl]amino]acetic acid
2-[[(3R)-4-(4-Tert-butylphenyl)-3-[[2-(4-methoxyphenyl)sulfanyl-5-[methyl(propan-2-yl)sulfamoyl]benzoyl]amino]butanoyl]amino]acetic acid
SMILES |
CC(C)N(C)S(=O)(=O)C1=CC(=C(C=C1)SC2=CC=C(C=C2)OC)C(=O)N[C@H](CC3=CC=C(C=C3)C(C)(C)C)CC(=O)NCC(=O)O |
InChIKey |
POBZRCRFILRWTQ-RUZDIDTESA-N |
Chemical Properties
Hydrogen bond acceptors |
None |
Hydrogen bond donors |
None |
Rotatable bonds |
None |
Molecular weight (Da) |
|
Bioactivities
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
Receptor |
Activity |
Source |
Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
2-[[(3R)-4-(4-Tert-butylphenyl)-3-[[2-(4-methoxyphenyl)sulfanyl-5-[methyl(propan-2-yl)sulfamoyl]benzoyl]amino]butanoyl]amino]acetic acid
Drug properties
Molecular type |
Small molecule |
Physiological/Surrogate |
Surrogate |
Approved drug |
No |
Clinical Trials
Phase I
0
Phase II
0
Phase III
0
Approved
No
Sankey plot
Compound is not listed as a drug.